title: Accelerated growth signals and low tumor-infiltrating lymphocyte levels predict poor outcome in T4 esophageal squamous cell carcinoma.
abstract: BACKGROUND
  Little is known about the biological nature of T4 esophageal carcinoma growth signals and host defenses.
  
  
  METHODS
  Paraffin-embedded sections from 78 patients with T2 to T4 esophageal squamous cell carcinoma who underwent operation were analyzed with immunohistochemistry.
  
  
  RESULTS
  Positive cyclin A showed a significantly greater increase in T4 tumors than in those of other stages, and negative p27 showed a significantly greater decrease in T4 tumors than in large T3 stage tumors (tumor size > or = 4.0 cm). Patients with low-grade tumor-infiltrating lymphocyte (TIL) density showed a significantly greater decrease in T4 than in T2. The combination of p27 and cyclin A was a significant independent prognostic factor among T and N factors in multivariate analysis. TIL density was an independent prognostic factor among immunonutritional variables such as serum albumin concentration and the number of total blood lymphocytes.
  
  
  CONCLUSIONS
  T4 esophageal squamous cell carcinoma has a poor prognosis, which is associated with increased p27-negative and cyclin A-positive growth signals in the tumor and with low TIL density in the host.
authors.affiliation: First Department of Surgery, School of Medicine, Kumamoto University, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Yasunaga
authors.forename: Y
authors.initials: Y
authors.lastname: Tabira
authors.forename: K
authors.initials: K
authors.lastname: Nakano
authors.forename: S
authors.initials: S
authors.lastname: Iida
authors.forename: N
authors.initials: N
authors.lastname: Ichimaru
authors.forename: N
authors.initials: N
authors.lastname: Nagamoto
authors.forename: T
authors.initials: T
authors.lastname: Sakaguchi
mesh_terms: D017209:Apoptosis; D015415:Biomarkers / Q000032:analysis*; D002294:Carcinoma, Squamous Cell / Q000401:mortality* / Q000473:pathology*; D002452:Cell Count; D019925:Cyclin A / Q000032:analysis*; D004938:Esophageal Neoplasms / Q000401:mortality* / Q000473:pathology*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D016246:Lymphocytes, Tumor-Infiltrating / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis*
chemical_list: D015415:Biomarkers; D019925:Cyclin A; D018809:Proliferating Cell Nuclear Antigen; C413374:p27 antigen